Dr. Sonja D Bartolome M.D.

Cystic fibrosis (CF) is an inherited disease that is caused by a defect in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. The CFTR protein is responsible for controlling the transportation of salt in and out of cells. Any mutations in the CFTR gene can cause an imbalance in the...

What is Bronchitis?Bronchitis is a pulmonary disorder that occurs due to inflammation of airway lining of the lungs, resulting in respiratory distress. Bronchitis is often characterized by cough that produces thick mucus (phlegm) often yellowish-green in color, indicating an underlying infection. ...

Patients who are diagnosed with chronic obstructive pulmonary disease (COPD) should expect mucus production that is tenacious, long-term coughing, and extreme fatigue. The main concern with COPD is if permanent scars have developed in the lungs. If scarring does occur, the condition cannot be cured...

Cystic fibrosis is considered incurable, and is a daily struggle for all of those who have it. Constant research is being poured into finding better treatment, and potentially even a cure, but Rowan's Public Relations Student Society of America (PRSSA) is putting their own spin (literally) on...

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

For the first time, two of the world’s largest Cystic Fibrosis (CF) charities, UK’s CF Trust and CF Canada, have joined hands for an international study.They will partner in the Trust’s CLIMB CF study to test the value of using home monitoring devices to track the health status and treatment...